Home » Topics » Regulatory » Patents

Patents
RSS

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

MAb 1DT3-D disclosed for treatment of B-cell lymphoma

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Antiplatelet agents from Taisho

Oct. 18, 1996

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Benzimidazole derivatives for use in heart failure

Oct. 18, 1996

Tsumura discloses agents for atherosclerosis

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...